The submission deadline has passed. Thanks to all who submitted an abstract. 

2024 Spring Meeting Call for Abstracts

We want to hear about your efforts to enhance quality, care delivery, and the patient experience. Share your innovative project, program or best practice!

The Northern New England Clinical Oncology Society seeks abstracts on innovative hematology/oncology topics to share knowledge during the Spring Meeting. Physicians, nurses, advanced practice nurses and PAs, ancillary health care providers (psychologists, physical therapists, etc.), administrators, pharmacists, and post-graduate trainees (fellows, residents, students) are invited* to submit abstracts. (*Employees of pharmaceutical companies are not eligible.) Abstracts previously submitted to ONS, ASCO, ASH, etc. are acceptable. NNECOS reserves the right to review and accept submissions.

Poster Presentation

Authors of accepted abstracts will be invited to present a virtual poster on Saturday, March 23, 2024.

Podium Presentation

Three abstracts will be selected for oral presentations on Saturday, March 23, 2024The responsible first author will receive a $250 stipend. 

Selected Areas/Topics:

Topics centered around the theme of New Horizons in Survivorship are strongly encouraged.

Abstracts Guidelines:

  • 250 words or less (strictly enforced)
  • Affiliations clearly listed
  • Submission should be divided into the following sections: Background, Methods, Results and Conclusions
  • Submitted electronically via NNECOS website (click on "Register" to access the submission form).
  • First authors will receive e-mail verification of receipt.

Podium Consideration Submission Deadline: Friday, January 19, 2024.

Poster Consideration Submission Deadline: Friday, February 23, 2024.

Contact Information

Your name, institution, address, telephone number, fax number, and eĀ­mail address. As the First Author (presenter), you will receive all future correspondence from NNECOS.

Abstract Title

The title of your abstract in sentence case, capitalizing only the first letter of the first word of the title and any proper nouns or acronyms. Do not use proprietary drug names in the title; use generic drug names instead. Do not refer to study results or conclusions in the title; it should objectively describe the study.  NNECOS reserves the right to edit abstract titles to conform to this policy.


The name and institution of each coauthor.

Disclosure Declaration

Abstract submissions must be accompanied by an abstract disclosure form for all authors. File attachments should be uploaded at the time of submission.


The First Author must

  • Verify that all coauthors are aware of the contents of the abstract and support its data.
  • Agree, on behalf of all coauthors, to transfer copyright to NNECOS for publication in the spring meeting proceedings and on the NNECOS website.
  • Agree to deliver an oral presentation if selected (first authors may indicate desire to be considered for poster presentation only)
  • Agree to be present during the scheduled time of a Poster Session
  • Adhere to the following conflict of interest policy


NNECOS must ensure fair balance, independence, objectivity, and scientific rigor in all of its educational activities through appropriate disclosure of financial interests, among other things. The following interests or relationships must be disclosed: employment or leadership position, advisory role, stock ownership, honoraria, research funding, expert testimony, and other remuneration. It is the responsibility of the First Author to obtain disclosure information from all coauthors and to provide all disclosure of such interests and relationships at the time of submission.

Check out our video: Making a Poster!

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948

This website brought to you by:

Powered by Wild Apricot Membership Software